Transmission Dynamics of Mpox in Peru During the 2022 Outbreak

M. Gabriela Soto-Cabezas Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by M. Gabriela Soto-Cabezas in
Current site
Google Scholar
PubMed
Close
,
Adrián Vásquez-Mejía Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Adrián Vásquez-Mejía in
Current site
Google Scholar
PubMed
Close
,
Martha Calderón Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Martha Calderón in
Current site
Google Scholar
PubMed
Close
,
Mary Reyes-Vega Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;
Emerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru

Search for other papers by Mary Reyes-Vega in
Current site
Google Scholar
PubMed
Close
,
Yrene I. Blancas-Blas Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Yrene I. Blancas-Blas in
Current site
Google Scholar
PubMed
Close
,
Anderson N. Soriano-Moreno Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;
Emerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru

Search for other papers by Anderson N. Soriano-Moreno in
Current site
Google Scholar
PubMed
Close
,
María A. Vargas Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by María A. Vargas in
Current site
Google Scholar
PubMed
Close
,
Kely R. Meza Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Kely R. Meza in
Current site
Google Scholar
PubMed
Close
,
Jorge R. Uchuya Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Jorge R. Uchuya in
Current site
Google Scholar
PubMed
Close
,
Diego Castro-Garro Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Diego Castro-Garro in
Current site
Google Scholar
PubMed
Close
,
Sergio Luque-Mamani Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Sergio Luque-Mamani in
Current site
Google Scholar
PubMed
Close
,
Oswaldo G. E. Espinoza-Hurtado Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;

Search for other papers by Oswaldo G. E. Espinoza-Hurtado in
Current site
Google Scholar
PubMed
Close
, and
Cesar V. Munayco Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú;
Emerge, Emerging Diseases and Climate Change Research Unit, School of Public Health and Administration, Universidad Peruana Cayetano Heredia, San Martin de Porres, Peru

Search for other papers by Cesar V. Munayco in
Current site
Google Scholar
PubMed
Close
Restricted access

In July 2022, mpox was declared an international public health emergency because of a surge in cases across Europe and America. This study assessed transmission dynamics and factors associated with hospitalization during the 2022 mpox outbreak in Peru. We performed a cross-sectional study using the Surveillance System of the National Center of Epidemiology, Prevention, and Disease Control (CDC-Peru) data. We estimated the basic reproduction number (R0), effective reproduction number (Rt), and the duration of the outbreak phases. We conducted mathematical modeling of the outbreak and estimated the serial interval. Additionally, we used Poisson regression with robust variance to identify hospitalization factors, using prevalence ratio. Between July and December 2022, 3,677 confirmed cases (96.3% male, mean age 32.6 years) were reported to the CDC-Peru. Of these, 75.0% were men who have sex with men (MSM), 55.6% had HIV infection, and 5.2% were hospitalized. The R0 was 2.37, with an exponential growth phase lasting 7 weeks, and Rt dropped to non-epidemic levels after 14 weeks. The incubation period and recovery period were estimated to be 6 days and 22 days, respectively. The serial interval was 9.3 days. HIV infection increased hospitalization risk. The 2022 mpox outbreak in Peru was characterized by primarily affecting a young MSM population, with a significant proportion being people living with HIV. Hospitalization was associated with HIV coinfection. This outbreak showed exponential growth during the first 7 weeks, followed by a marked deceleration of transmission.

    • Supplemental Materials (PDF 1419.4 KB)

Author Notes

Financial support: This project received funding from the National Center of Epidemiology, Prevention, and Disease Control (CDC-Peru). Reyes-Vega y Soriano-Moreno are supported by the Emerge: Emerging Diseases Epidemiology Research Training Grant from the Fogarty International Center of the US National Institutes of Health (Grant No. 2D43TW007393-16). The funders had no involvement in the study design, data collection and analysis, decision to publish, or manuscript preparation.

Disclosures: This work was supported by the National Center of Epidemiology, Prevention, and Disease Control (CDC-Peru). The funder had no role in the conceptualization of the paper or in the material presented. Most authors work at CDC-Peru. However, the opinions expressed in this article are those of the authors and do not necessarily reflect the policy or official position of the institutions where the authors work. The study was approved by the ethics committee on research at the National Institute of Health of Peru (INS) (#OE-042-22–Letter No. 2442-2022-OGITT/INS) and has approval from CDC-Peru (file No. 20230000535).

Current contact information: M. Gabriela Soto-Cabezas, Adrián Vásquez-Mejía, Martha Calderón, Mary Reyes-Vega, Yrene I. Blancas-Blas, Anderson N. Soriano-Moreno, María A. Vargas Huapaya, Kely R. Meza, Jorge R. Uchuya, Diego Castro-Garro, Sergio Luque-Mamani, Oswaldo G. E. Espinoza-Hurtado, and Cesar V. Munayco, Centro Nacional de Epidemiología, Prevención y Control de Enfermedades, Lima, Perú, E-mails: msoto@minsa.gob.pe, apvasquez.md@gmail.com, mcalderon@dge.gob.pe, mreyes@dge.gob.pe, yblancas@dge.gob.pe, anderson.soriano@upch.pe, mvargas@dge.gob.pe, kelymeza@gmail.com, juchuya@dge.gob.pe, castrogda@gmail.com, serluquem@gmail.com, ozzespinoza27@gmail.com, and cmunayco@minsa.gob.pe.

Address correspondence to M. Gabriela Soto-Cabezas, Ministerio de Salud, Calle Daniel Olaechea 199, Jesús María 15072, Lima, Peru. E-mail: msoto@minsa.gob.pe
Past two years Past Year Past 30 Days
Abstract Views 719 719 719
Full Text Views 11 11 11
PDF Downloads 13 13 13
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save